SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-003491
Filing Date
2015-05-07
Accepted
2015-05-07 07:00:43
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nerv-10q_20150331.htm 10-Q 1079604
2 EX-10.5 nerv-ex105_20150331184.htm EX-10.5 17383
3 EX-31.1 nerv-ex311_201503318.htm EX-31.1 14082
4 EX-31.2 nerv-ex312_201503316.htm EX-31.2 13878
5 EX-32.1 nerv-ex321_201503317.htm EX-32.1 9677
  Complete submission text file 0001564590-15-003491.txt   5132664

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nerv-20150331.xml EX-101.INS 529216
7 XBRL TAXONOMY EXTENSION SCHEMA nerv-20150331.xsd EX-101.SCH 45147
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nerv-20150331_cal.xml EX-101.CAL 45698
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20150331_def.xml EX-101.DEF 158572
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20150331_lab.xml EX-101.LAB 345223
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20150331_pre.xml EX-101.PRE 289586
Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 15839338
SIC: 2834 Pharmaceutical Preparations